Cite
HARVARD Citation
Taschner-Mandl, S. et al. (n.d.). 1401 Metronomic topotecan causes a favorable type of therapy-inducedsenescence and prolongs survival in MYCN amplified neuroblastoma xenografts. European journal of cancer. pp. S198-. [Online].